SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Boston Scientific (BSX) Any Comments??? -- Ignore unavailable to you. Want to Upgrade?


To: John Carragher who wrote (461)8/27/1998 9:25:00 AM
From: yard_man  Read Replies (1) | Respond to of 798
 
Thanks, John. Appreciated the post. You post both the good and the not so good. I like to read it all.

Once the blood vessels weaken, I suppose there are really only a couple of choices, stents or bypass. It seems like the best approach would be to detect and stop the degenerative effects long before they happen. Our western approach leaves something to be desired, I think.



To: John Carragher who wrote (461)8/27/1998 10:09:00 AM
From: yard_man  Respond to of 798
 
Boston Scientific sets 2-for-1 stock split

biz.yahoo.com

Good timing, eh?